Literature DB >> 27005806

Feasibility study of axillary reverse mapping for patients with clinically node-negative breast cancer.

M Noguchi2, M Noguchi2, Y Ohno1, E Morioka1, Y Nakano1, T Kosaka3, N Kurose4, H Minato4.   

Abstract

BACKGROUND: The axillary reverse mapping (ARM) procedure was developed to identify and preserve arm lymphatic drainage during axillary lymph node dissection (ALND), thereby theoretically reducing the incidence of arm lymphedema. However, the oncological safety of this procedure has not yet been determined.
METHODS: Two hundred ninety-two patients with clinically negative nodes (cN0) underwent both sentinel lymph node (SLN) biopsy and ARM. SLN was identified by dye and gamma probe methods, and ARM nodes were identified using a fluorescence imaging system. If SLN was histologically positive, ALND was performed with removal of ARM nodes. Otherwise, identified ARM nodes were preserved unless they coincided with SLN. Postoperatively, SLN as well as ARM nodes were histologically examined with H&E staining.
RESULTS: SLN was identified in 286 of 292 patients, and ARM nodes were identified in 90 patients. In 54 patients with positive SLN, SLN was the same as the ARM node in 19 patients (the concordance type), whereas it was not an ARM node in the remaining 35 patients (the separate type). Non-SLN and ARM node was not involved in 51 of 54 patients with positive SLN, while it was involved in 3 patients of the concordance type.
CONCLUSIONS: When ARM nodes were involved in patients with cN0, these were most often the SLN-ARM nodes. Therefore, it may be concluded that ARM nodes that do not coincide with SLNs might be preserved during ALND in SLN-positive patients.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Axillary reverse mapping; Breast cancer; Fluorescence imaging; Sentinel lymph node biopsy

Mesh:

Substances:

Year:  2016        PMID: 27005806     DOI: 10.1016/j.ejso.2016.02.244

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  5 in total

Review 1.  Axillary surgery for breast cancer: past, present, and future.

Authors:  Masakuni Noguchi; Masafumi Inokuchi; Miki Noguchi; Emi Morioka; Yukako Ohno; Tomoko Kurita
Journal:  Breast Cancer       Date:  2020-11-09       Impact factor: 4.239

Review 2.  Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments.

Authors:  Tessa C Gillespie; Hoda E Sayegh; Cheryl L Brunelle; Kayla M Daniell; Alphonse G Taghian
Journal:  Gland Surg       Date:  2018-08

3.  The involvement of axillary reverse mapping nodes in patients with clinically node-negative breast cancer.

Authors:  M Noguchi; M Inokuchi; M Yokoi-Noguchi; E Morioka
Journal:  Breast Cancer       Date:  2021-09-30       Impact factor: 4.239

Review 4.  Lymphedema in survivors of breast cancer.

Authors:  Lin He; Huili Qu; Qian Wu; Yuhua Song
Journal:  Oncol Lett       Date:  2020-01-16       Impact factor: 2.967

5.  Clinical application of axillary reverse mapping in patients with breast cancer: A systematic review and meta-analysis.

Authors:  Wilson A Wijaya; Jing Peng; Yinhai He; Junjie Chen; Ying Cen
Journal:  Breast       Date:  2020-08-18       Impact factor: 4.380

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.